LATIN AMERICA
Social and economic impact
PROBIOMED ’ s production line is a complicated network of elements , including the Mexican health system ’ s priorities , economic and social impact , proven efficiency of reference drugs , and production complexity . The company is able to provide higher added value to society while reducing its competition , since PROBIOMED ’ s products require highly specialized processes . Offering biosimilar products at affordable prices translates into enabling health agencies to provide affordable treatment to a larger number of patients . For example , erythropoietin ( used for treatment of anemia caused by CKD and chemotherapy patients ) had a valid patent until 2001 . Then , the Mexican health systems could only provide treatment for 3,500 patients due to the drug ’ s high costs , but once biosimilar products became available , its price was reduced by 90 percent between 2001 and 2007 . This increased treatment availability to 80,000 patients , and saved the healthcare system a total of $ 398.3 million .
“ The social and economical impact from biosimilars is very strong . Being able to improve our health systems and patients ’ budgets has earned us a strong reputation as one of Mexico ’ s most added-value manufacturing companies ,” Sanchez said .
Key People
Jaime Uribe de la Mora Founder & President of PROBIOMED
PROBIOMED has delivered results , proving its commitment to biotech developments able to help Mexico ’ s population
www . probiomed . com . mx 83